FDA Drug Approvals and Regulatory Updates Drug Pharmacologic class Indication More information Cardiovascular Disease Tryngolza (olezarsen) Apolipoprotein ...
People living with HIV are demanding constant supply of quality and standard Antiretroviral (ARVs). This follows an outcry ...
HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.
Travel Noire on MSN
What your travel vaccinations actually cover, and what they don’t
The most expensive souvenir from a trip can be a fever you never budgeted for.
Multiple new clinical trials are underway to evaluate if various treatments will prove effective against the Bundibugyo Ebola ...
NCCN now recommends pemivibart pre-exposure prophylaxis for patients with B-cell lymphomas and other profoundly ...
Morning Overview on MSN
A new antiviral pill won approval to help prevent COVID-19 after a known exposure
Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick ...
The US Food and Drug Administration has approved Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older. HealthDay ...
(HealthDay News) — The US Food and Drug Administration has approved Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and ...
The oral regimen significantly cuts risk for symptomatic COVID-19 following a household exposure. (HealthDay News) — The U.S. Food and Drug Administration has approved Xocova (ensitrelvir), an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results